Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 73 articles:
HTML format
Text format



Single Articles


    November 2017
  1. DURAES LC, Stocchi L, Steele SR, Kalady MF, et al
    The Relationship Between Clavien-Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6142.
    PubMed     Text format     Abstract available


    October 2017
  2. TIERNAN JP, Jayne DG
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis.
    Ann Surg Oncol. 2017 Oct 31. doi: 10.1245/s10434-017-6200.
    PubMed     Text format    


  3. OH BY, Park YA, Huh JW, Yun SH, et al
    Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6135.
    PubMed     Text format     Abstract available


  4. POVOSKI SP, Hatzaras IS, Mojzisik CM, Arnold MW, et al
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6201.
    PubMed     Text format    


  5. WATANABE K, Salah S, Saito N
    Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6199.
    PubMed     Text format    


  6. BINAY SAFER V, Safer U, Yorulmaz E, Sahin Z, et al
    Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6166.
    PubMed     Text format    


  7. KLAVER CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, et al
    Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6037.
    PubMed     Text format     Abstract available


  8. PASSOT G, Kim BJ, Glehen O, Mehran RJ, et al
    Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141.
    PubMed     Text format     Abstract available


  9. SHIDA D, Tsukamoto S, Ochiai H, Kanemitsu Y, et al
    Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6133.
    PubMed     Text format     Abstract available


    September 2017
  10. CLARKE CN, Lee MS, Wei W, Manyam G, et al
    Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Ann Surg Oncol. 2017 Sep 21. doi: 10.1245/s10434-017-6054.
    PubMed     Text format     Abstract available


  11. DEMEY K, Wolthuis A, de Buck van Overstraeten A, Fieuws S, et al
    External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Sep 11. doi: 10.1245/s10434-017-6042.
    PubMed     Text format     Abstract available


  12. MATSUDA T, Sumi Y, Yamashita K, Hasegawa H, et al
    Anatomy of the Transverse Mesocolon Based on Embryology for Laparoscopic Complete Mesocolic Excision of Right-Sided Colon Cancer.
    Ann Surg Oncol. 2017 Sep 5. doi: 10.1245/s10434-017-6070.
    PubMed     Text format     Abstract available


    July 2017
  13. WATT DG, Ramanathan ML, McSorley ST, Walley K, et al
    Clinicopathological Determinants of an Elevated Systemic Inflammatory Response Following Elective Potentially Curative Resection for Colorectal Cancer.
    Ann Surg Oncol. 2017 Jul 10. doi: 10.1245/s10434-017-5987.
    PubMed     Text format     Abstract available


    June 2017
  14. HA GW, Kim JH, Lee MR
    Oncologic Impact of Anastomotic Leakage Following Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2017 Jun 12. doi: 10.1245/s10434-017-5881.
    PubMed     Text format     Abstract available


    May 2017
  15. D'ANGELICA MI
    Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board?
    Ann Surg Oncol. 2017 May 31. doi: 10.1245/s10434-017-5908.
    PubMed     Text format    


  16. SIMPSON AL, Doussot A, Creasy JM, Adams LB, et al
    Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5896.
    PubMed     Text format     Abstract available


  17. YOU YN, Shiozaki H, Lee JE, Passot G, et al
    Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection.
    Ann Surg Oncol. 2017 May 16. doi: 10.1245/s10434-017-5878.
    PubMed     Text format     Abstract available


    March 2017
  18. MCSORLEY ST, Roxburgh CS, Horgan PG, McMillan DC, et al
    The Impact of Preoperative Dexamethasone on the Magnitude of the Postoperative Systemic Inflammatory Response and Complications Following Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2017 Mar 1. doi: 10.1245/s10434-017-5817.
    PubMed     Text format     Abstract available


    February 2017
  19. ALI SM, Pawlik TM, Rodriguez-Bigas MA, Monson JR, et al
    Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2017 Feb 21. doi: 10.1245/s10434-016-5745.
    PubMed     Text format     Abstract available


  20. CAVNAR MJ, Turcotte S, Katz SC, Kuk D, et al
    Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.
    Ann Surg Oncol. 2017 Feb 17. doi: 10.1245/s10434-017-5812.
    PubMed     Text format     Abstract available


    January 2017
  21. ALOTAIBI AM, Lee JL, Kim J, Lim SB, et al
    Prognostic and Oncologic Significance of Perineural Invasion in Sporadic Colorectal Cancer.
    Ann Surg Oncol. 2017 Jan 9. doi: 10.1245/s10434-016-5748.
    PubMed     Text format     Abstract available


    December 2016
  22. XIE D, Yu C, Gao C, Osaiweran H, et al
    An Optimal Approach for Laparoscopic D3 Lymphadenectomy Plus Complete Mesocolic Excision (D3+CME) for Right-Sided Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  23. NAGATA H, Ishihara S, Hata K, Murono K, et al
    Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  24. KIM JE, Hong YS, Kim HJ, Kim KP, et al
    Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  25. KITAHARA T, Haraguchi N, Takahashi H, Nishimura J, et al
    Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  26. WATT DG, McSorley ST, Park JH, Horgan PG, et al
    A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  27. LISKA D, Stocchi L, Karagkounis G, Elagili F, et al
    Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  28. KIM TJ, Kim ER, Hong SN, Kim YH, et al
    Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  29. BECERRA AZ, Aquina CT, Mohile SG, Tejani MA, et al
    Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  30. VAN DE GRAAF FW, Lange MM, Menon AG, O'Mahoney PR, et al
    Erratum to: Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  31. KIM CG, Ahn JB, Jung M, Beom SH, et al
    Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  32. VAN DEGRAAF FW, Lange MM, Menon AG, O'Mahoney PR, et al
    Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  33. NAVEZ J, Remue C, Leonard D, Bachmann R, et al
    Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  34. KATAOKA M, Kanda M, Ishigure K, Matsuoka H, et al
    Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  35. CIENFUEGOS JA, Martinez P, Baixauli J, Beorlegui C, et al
    Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  36. BECERRA AZ, Berho ME, Probst CP, Aquina CT, et al
    Variation in Hospital-Specific Rates of Suboptimal Lymphadenectomy and Survival in Colon Cancer: Evidence from the National Cancer Data Base.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  37. KATAOKA M, Kanda M, Ishigure K, Matsuoka H, et al
    The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  38. BARATTI D, Kusamura S, Iusco D, Gimondi S, et al
    Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  39. TAN CN, Chong CS, Fong YF, Rauff S, et al
    Laparoscopic Anterior Resection with Transvaginal Specimen Extraction (TVSE) for Colorectal Cancer and Concomitant Total Hysterectomy and Bilateral Salpingo-Oophrectomy (THBSO): A Technical Description.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  40. NISHIZAWA Y, Nishida N, Konno M, Kawamoto K, et al
    Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  41. DURAES LC, Stocchi L, Dietz D, Kalady MF, et al
    The Disproportionate Effect of Perioperative Complications on Mortality within 1 Year After Colorectal Cancer Resection in Octogenarians.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  42. KARANICOLAS PJ, Ko YJ
    Hepatic Arterial Infusion for Unresectable Liver Metastases from Colorectal Cancer: The Dawn of a New Era?
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  43. LAO X, Feng Q, He G, Ji M, et al
    Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  44. AMRI R, England J, Bordeianou LG, Berger DL, et al
    Risk Stratification in Patients with Stage II Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  45. YAMAMOTO H, Maeda K, Arima H, Sonoda H, et al
    Perioperative Adiponectin Measurement is Useful for Prediction of Postoperative Infection in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  46. CHEMAMA S, Bayar MA, Lanoy E, Ammari S, et al
    Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  47. SHIDA D, Hamaguchi T, Ochiai H, Tsukamoto S, et al
    Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  48. SUGIMACHI K, Matsumura T, Shimamura T, Hirata H, et al
    Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  49. PATEL D, Townsend AR, Karapetis C, Beeke C, et al
    Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  50. LIM C, Doussot A, Osseis M, Salloum C, et al
    Primary Tumor Versus Liver-First Strategy in Patients with Stage IVA Colorectal Cancer: A Propensity Score Analysis of Long-term Outcomes and Recurrence Pattern.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  51. TARANTINO I, Huttner FJ, Warschkow R, Schmied BM, et al
    Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
    Ann Surg Oncol. 2016;23:1576-86.
    PubMed     Text format     Abstract available


  52. COLOMBO PE, Bertrand MM, Alline M, Boulay E, et al
    Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach? : A Single-Center Series of 120 Consecutive Patients.
    Ann Surg Oncol. 2016;23:1594-600.
    PubMed     Text format     Abstract available


    March 2016
  53. LEE SJ, Kang BW, Chae YS, Kim HJ, et al
    Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2016;23:894-9.
    PubMed     Text format     Abstract available


  54. ROBINSON C, Artinyan A
    Pushing the Limits of Local Excision for Rectal Cancer: Transanal Minimally Invasive Surgery (TAMIS) for Rectal Cancer Using the Port-in-Port Technique.
    Ann Surg Oncol. 2016;23:918.
    PubMed     Text format     Abstract available


  55. HUNTINGTON CR, Boselli D, Symanowski J, Hill JS, et al
    Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2016;23:877-87.
    PubMed     Text format     Abstract available


  56. ZIMMITTI G, Soliz J, Aloia TA, Gottumukkala V, et al
    Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2016;23:1003-11.
    PubMed     Text format     Abstract available


  57. LUDMIR EB, Arya R, Wu Y, Palta M, et al
    Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era.
    Ann Surg Oncol. 2016;23:856-62.
    PubMed     Text format     Abstract available


  58. MAILLET M, Glehen O, Lambert J, Goere D, et al
    Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study.
    Ann Surg Oncol. 2016;23:863-9.
    PubMed     Text format     Abstract available


  59. CHANG SC, Lin PC, Lin JK, Lin CH, et al
    Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
    Ann Surg Oncol. 2016;23:849-55.
    PubMed     Text format     Abstract available


  60. LEOWARDI C, Schneider ML, Hinz U, Harnoss JM, et al
    Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Ann Surg Oncol. 2016;23:870-6.
    PubMed     Text format     Abstract available


  61. SIMKENS GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, et al
    Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2016;23:833-41.
    PubMed     Text format     Abstract available


    February 2016
  62. MATSUMOTO Y, Tsujimoto H, Ono S, Shinomiya N, et al
    Abdominal Infection Suppresses the Number and Activity of Intrahepatic Natural Killer Cells and Promotes Tumor Growth in a Murine Liver Metastasis Model.
    Ann Surg Oncol. 2016;23 Suppl 2:S257-65.
    PubMed     Text format     Abstract available


  63. MAEDA Y, Shinohara T, Nagatsu A, Futakawa N, et al
    Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2016;23 Suppl 2:S242-8.
    PubMed     Text format     Abstract available


  64. KOYAMA M, Murata A, Sakamoto Y, Morohashi H, et al
    Risk Factors for Anastomotic Leakage After Intersphincteric Resection Without a Protective Defunctioning Stoma for Lower Rectal Cancer.
    Ann Surg Oncol. 2016;23 Suppl 2:S249-56.
    PubMed     Text format     Abstract available


  65. KENG C, Coates A, Grubac V, Lovrics P, et al
    The Need for Consensus and Transparency in Assessing Population-Based Rates of Positive Circumferential Radial Margins in Rectal Cancer: Data from Consecutive Cases in a Large Region of Ontario, Canada.
    Ann Surg Oncol. 2016;23:397-402.
    PubMed     Text format     Abstract available


  66. YAMAMOTO H, Tomita N, Inomata M, Furuhata T, et al
    OSNA-Assisted Molecular Staging in Colorectal Cancer: A Prospective Multicenter Trial in Japan.
    Ann Surg Oncol. 2016;23:391-6.
    PubMed     Text format     Abstract available


  67. TOKUNAGA R, Sakamoto Y, Nakagawa S, Miyake K, et al
    The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer.
    Ann Surg Oncol. 2016;23:678-85.
    PubMed     Text format     Abstract available


  68. DOWNS-CANNER S, Magge D, Ravindranathan R, O'Malley ME, et al
    Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer.
    Ann Surg Oncol. 2016;23:655-62.
    PubMed     Text format     Abstract available


  69. NISHIGORI N, Koyama F, Nakagawa T, Nakamura S, et al
    Visualization of Lymph/Blood Flow in Laparoscopic Colorectal Cancer Surgery by ICG Fluorescence Imaging (Lap-IGFI).
    Ann Surg Oncol. 2016;23 Suppl 2:S266-74.
    PubMed     Text format     Abstract available


  70. YAMADA T, Okabayashi K, Hasegawa H, Tsuruta M, et al
    Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery.
    Ann Surg Oncol. 2016;23 Suppl 2:S236-41.
    PubMed     Text format     Abstract available


    January 2016
  71. WEISER MR
    Rectal Cancer: Time for Precision Medicine?
    Ann Surg Oncol. 2016;23:12-5.
    PubMed     Text format    


  72. KULU Y, Tarantino I, Billeter AT, Diener MK, et al
    Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Ann Surg Oncol. 2016;23:106-13.
    PubMed     Text format     Abstract available


  73. SIMKENS GA, van Oudheusden TR, Braam HJ, Luyer MD, et al
    Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters.
    Ann Surg Oncol. 2016;23:99-105.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: